Shepherd Kaplan Krochuk, LLC Gilead Sciences, Inc. Transaction History

Shepherd Kaplan Krochuk, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $18,000 - $20,537	-300 Reduced 7.5%	3,700 $239,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $39,655 - $45,185	-700 Reduced 14.89%	4,000 $233,000
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $86,940 - $109,312	-1,400 Reduced 22.95%	4,700 $297,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $28,936 - $33,600	400 Added 7.02%	6,100 $469,000
Q1 2020 May 12, 2020	SELL	$62.63 - $80.22 $521,770 - $668,312	-8,331 Reduced 59.38%	5,700 $426,000
Q2 2019 Aug 12, 2019	SELL	$61.87 - $69.38 $307,432 - $344,749	-4,969 Reduced 26.15%	14,031 $948,000
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $525,252 - $588,420	8,400 Added 79.25%	19,000 $1.24 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $254,940 - $310,800	-3,500 Reduced 24.82%	10,600 $799,000
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $10,032 - $11,776	-141 Reduced 0.99%	14,100 $1.01 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.03 Million - $1.22 Million	14,241	14,241 $1.15 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Shepherd Kaplan Krochuk, LLC, based on Form 13F filings with the SEC.

Stay updated on Shepherd Kaplan Krochuk, LLC with notifications on news.